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Abstract
Background: The Zika virus epidemic in Latin America has elicited official recommendations for women to delay or
avoid pregnancy in affected countries, which has increased demand for family planning services. It is likely, however,
that health facilities in areas where the population is most vulnerable to the disease lack the capacity to
respond to the increased demand for family planning services. Our objectives are to perform facilities assessment and
understand client perceptions in areas affected by Zika virus, and to track changes in these parameters over time.
Methods/design: We will collaborate with local health authorities to map facilities that have the capacity to provide
services in contraception and safe abortion, including induced abortion to the full extent of the law and post-abortion
care for treatment of complications from unsafe abortion and post-abortion contraception. We then will carry out a survey
of facilities to assess the availability of services and their readiness to provide contraception and safe abortion care. All
facilities will be assessed for baseline readiness and availability of services, and a random subsample of surveyed facilities
will be reassessed in second and third rounds of surveys. Focus group interviews with clients will be conducted as part of
the facilities surveys in order to gain an understanding of the community’s knowledge, needs and perceived barriers to
healthcare in the context of the Zika virus epidemic.
Discussion: The findings of this study will aid the response to Zika virus ranging from the identification of healthcare
facilities that can be potentially strengthened, to the formulation of interventions to reduce barriers and
improve readiness of facilities to provide contraception and safe abortion services. Lessons learned from this study will
help to build and strengthen health systems that are more prepared to consistently providing reproductive healthcare
services in the context of health emergencies.
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Plain English Summary
In the wake of the Zika virus epidemic in Latin America,
governments have suggested that women who want to
have children should wait before becoming pregnant to
reduce their risk of having a baby with microcephaly or
other abnormalities caused by Zika virus. If women are
to follow these recommendations, they will need family
planning services such as contraception and access to
safe abortion. It is likely, however, that healthcare
facilities in areas where women are most vulnerable to
Zika virus are not prepared for the increased demand for
family planning services. Our objective is to assess the
status of health facilities in areas affected by Zika virus.
Over the course of project timeline we will perform
three rounds of surveys of health facilities in affected
areas to determine what contraception, abortion and
post-abortion care services they provide and their readi-
ness to deliver these services. We will also conduct focus
group interviews with people who are served by the
facilities to gain an understanding of the community’s
knowledge, needs and perceived barriers to receiving
healthcare in the context of Zika virus.
This study will help us identify which facilities are pre-
pared to respond to the Zika virus epidemic, and which
need to be strengthened. It will also help identify general
gaps in services provided and barriers that women, men,
and adolescents must overcome to get the care that they
need. Lessons learned from this study will help to build
health systems that are more prepared to consistently
provide reproductive healthcare services in the context
of emergencies.
Background
Zika virus (ZIKV) is a mosquito borne virus that has been
shown to cause microcephaly and other severe brain
anomalies in newborns when the mother is infected pre-
natally [1, 2]. ZIKV during pregnancy can result in many
adverse events such as fetal deaths or newborns with
congenital abnormalities including microcephaly and
other neural irregularities [3, 4]. In light of this, the WHO
declared the ZIKV outbreak to be a Public Health Emer-
gency of International Concern (PHEIC) in February
2016. At this time, the WHO recommended that risk of
infection to women of reproductive age should be mini-
mized in affected countries and that the capacity for
surveillance of the disease should be strengthened [5].
Because of the possible adverse outcomes in pregnancy
caused by ZIKV, many women and adolescents want to
postpone or avoid pregnancies. Some health ministers in
Latin American countries have officially recommended
that women postpone or avoid pregnancy, and interim
recommendations from the WHO to prevent ZIKV
infection in affected areas include the provision of emer-
gency contraceptive services, counseling to women that
have had unprotected sex, and access to resources for
delaying pregnancy [6]. Regarding the risk of sexual
transmission of ZIKV, the official recommendations
encourage practicing safe sex with condoms to avoid con-
tinued spread of the disease [6]. We have already seen,
and further anticipate, a significant increase in demand for
both contraception and safe abortion services [7].
However, we suspect that facilities in the most affected
regions lack the capacity to respond to the increased
demand for family planning. There may be inadequate in-
frastructure and delivery systems, inadequate commodities
and supplies (including emergency contraception, long-
acting reversible contraception, condoms, electric and/or
manual and vacuum aspiration (MVA), and mifepristone
and misoprostol) and/or a lack of trained personnel to
provide quality care to meet the needs of the population.
Due to the suspected lack of provision of adequate contra-
ceptive and safe abortion services, as well as severely
restrictive abortion laws, we fear that many women will be
forced to choose clandestine and unsafe abortion
methods. This highlights the importance of readiness to
provide post-abortion care in these areas, even though
induced abortion may be illegal in many circumstances.
While the rate of modern contraception use in Latin
America and the Caribbean has increased and the fertility
rate has declined over recent decades [8, 9, 10] there are
still about 23 million women in the region who wish to
avoid pregnancy but are not using contraception [11] and
10% of all maternal deaths in the region are due to unsafe
abortion [12]. Additionally continuation rates for contra-
ception are especially low in Latin America [9]. All of
these factors likely contribute to the fact that the Latin
America and Caribbean region has the highest proportion
of unintended pregnancies in the world [13]. Additionally
97% of women of reproductive age in Latin America live
in areas where abortion is restricted or banned altogether
[14]. Within our study region, abortion is legal only in
cases of rape/incest, anencephalic fetus, or to save a
woman’s life in Brazil, and legal to save a woman’s life,
preserve her physical and/or mental health, in cases of
rape/incest, or because of fetal impairment in Colombia
[15]. While it is difficult for any woman to access to safe
abortion in Brazil, this is disproportionately true for
women of lower socio-economic status, and safe abortion
access in Brazil is one example of extreme inequity in
healthcare [10]. Access to family planning services are
likely inequitable in all of our study countries, which exac-
erbates the challenges presented by ZIKV.
As is commonly seen in public health emergencies,
disease burden is often highest for populations of lower
socioeconomic status due to a disproportionate lack of
access to quality health care. As was true with Ebola,
this is also likely the case for Zika virus [16, 17]. Poor
populations often have a greater risk of infection due to
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poor sanitation, lack of clean water, and overcrowding.
Additionally, higher-quality public and private health care
tend to be more readily available and accessible to people
of higher socioeconomic status, thus contributing to the
perpetual cycle of poor health and inequality, which is ex-
acerbated during epidemics or disasters [18]. In the Ebola
outbreak, many weak health systems quickly collapsed in
wake of the disease and failed to provide basic healthcare
to vulnerable populations. Though reproductive health
was crucial in the context of Ebola, which is suspected to
be sexually transmitted, health systems were not able to
provide adequate services for women and children, espe-
cially in the context of reproductive health [19, 20]. ZIKV
now puts a spotlight on the state of reproductive health
services in Latin America. In order to apply the lessons
learned from the Ebola outbreak and prevent the foreseen
exacerbation of existing gender inequalities and social
injustices [21], it will be essential to focus on ensuring
equitable quality care in reproductive health if we hope to
adequately serve the populations that are most vulnerable
to Zika virus.
Study aims and objectives
It is essential to gather data on the impact that Zika is
having in communities and on healthcare systems, and
little of this type of work has been done to date. We hope
to contribute to filling this evidence gap by conducting
facility assessment of contraception and safe abortion/
post-abortion care services available in ZIKV-affected
areas in Brazil, Honduras and Columbia. Through this
facility assessment, we will gather information on the
types of contraception and abortion/post-abortion care
services available in local health centers, and assess the
local health facilities’ readiness in addressing concerns and
providing quality care to clients of all socioeconomic
statuses. In assessment of abortion services, keeping in
mind that in many settings abortion is either highly re-
strictive or not permitted, we will follow the National
policy and guidelines and will assess only the services
allowed by law. We will also assess the client’s perspective
of services and barriers to utilization of services.
In the short-term we hope to begin to conduct a much
needed assessment of the state of facilities in ZIKV-
affected areas to provide the Ministries of Health with
information that will help them more equitably serve the
general population. The long-term goals that we hope to
achieve are to strengthen the health system’s response to
the sexual and reproductive health needs of the communi-
ties, and advocate for equitable access to essential repro-
ductive health services.
The specific objectives of this study are the following:
1. to create a map of all health facilities with the
capacity to provide contraceptive and abortion/post-
abortion care in the ZIKV-affected areas in Brazil,
Honduras and Columbia.
2. to conduct assessment of facilities selected at
subnational level that are most affected by ZIKV,
regarding availability and readiness to provide
services in contraception and abortion care,
including treatment of complications from unsafe
abortion and provision of post abortion contraception.
3. to assess client perceptions of services and barriers
to service utilization in selected ZIKV-affected areas.
4. to assess changes in availability and readiness of
facilities to provide services in contraception,
abortion and post abortion care, and changes in
client’s perspectives after Ministries of Health are
provided with baseline data and given time to make
changes to health systems.
Methods/design
This study will employ a quantitative survey and qualitative
stocktaking to assess health facilities and client perceptions.
The study will be carried out in collaboration with the
Ministries of Health in countries, with WHO regional and
country offices and with local academic institutions.
Mapping of facilities in ZIKV-affected areas
The principal investigator, with the help of the Minis-
tries of Health, will identify and map all facilities in iden-
tified ZIKV-affected areas in Brazil, Honduras and
Columbia with the potential to provide services in
contraception and safe abortion including treatment of
complications and provision of post abortion contracep-
tion care. The affected areas will be identified jointly by
the Ministry of health and WHO country office.
Health facilities surveys
The principal investigator will train the local project
team on the study purpose, design, quality assurance,
reporting mechanisms and data collection tools. All
facilities identified in the mapping activity will then be
visited, data collection will be done and assessed. This
data will generate evidence on availability of services and
health facilities’ readiness to deliver services in contra-
ceptive and abortion care and treatment of complica-
tions and provision of post abortion contraception care.
A cross-sectional panel survey design will be used. In
the first round of surveys, we plan to collect data from
all identified facilities’ records in the ZIKV-affected areas
with the potential to provide services in contraception,
safe abortion and post-abortion care. The survey team
will interview the person most knowledgeable (senior
health care provider and/or administrator) about contra-
ceptive and abortion care and treatment of complica-
tions and provision of post abortion contraception care
in the facility.
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Baseline data will be followed with two more data
points at 6 months and 12 months after the ministries of
health have received detailed feedback on the first data
report. It is expected that based on the findings the
Ministries of health will take corrective measures to
strengthen facilities. In the second and third phases of
data collection, we plan to use a random subsample of
the facilities from the original sampling framework to
assess trends in service availability and readiness over
time. We anticipate challenges in gathering data about
availability and readiness to perform safe abortions, but
in these cases we plan to still assess readiness and avail-
ability of services to provide post-abortion care.
The following aspects of facilities will be assessed
using validated tools:
1. supplies and equipment for contraception (adapted
from the Service Availability and Readiness
Assessment (SARA) guide laid out by the WHO)
[22].
2. safe abortion care and post abortion contraception
(adapted from the WHO’s safe abortion assessment
tool) [23].
3. Focus group discussion, adapted from Columbine M,
Busza J, Cleland J, Campbell O. Social science methods
for research on sexual and reproductive health. Geneva:
World Health Organization; 2012 [24].
Here “availability” refers to facility and health worker
physical locations, numbers, and distribution per capita.
“Readiness” refers to the capacity to deliver services
(including basic amenities, equipment and supplies,
diagnostics, essential medicines and commodities, and
competencies of healthcare providers).
Client’s perspective
A qualitative descriptive study with focus group inter-
views will be used to provide an in-depth understanding
of clients’ perspectives in ZIKV-affected areas. Using the
WHO’s guideline for focus group interviews, a guide for
focus group interview facilitators will be prepared by the
PIs and FGD experts by identifying the main objectives
of the meetings and developing key questions.
Information gathered will include:
1. knowledge about Zika virus (such as cause, signs and
symptoms)
2. care seeking and perception of risk about being infected
by Zika virus
3. knowledge about microcephaly and other
neurological defects related to Zika virus
4. needs related to sexual reproductive health services
(including contraception and abortion care)
5. barriers to accessing reproductive health services
Participants will be recruited for the focus group inter-
views based on criteria such as experiences on access to
particular health services, socio-demographic character-
istics and comfort with other fellow participants in the
group. The principal investigator and project team along
with local health authorities will visit the local commu-
nities to identify potential participants. We plan to
recruit participants who are women and men from all
socioeconomic backgrounds in the area, of reproductive
age, who have sought or tried to receive health services
from local health facilities. Two to three focus groups
will be interviewed in selected geographic area (state or
a district). We plan to follow these focus groups over
time, to understand the change in risk-perception, needs
and concerns regarding the Zika epidemic. Focus group
discussions will be conducted at the same time and in
the same place as facilities assessments to understand
how both factors change together over time.
Data management and analysis
A service readiness assessment will be conducted to fill
critical data gaps in service delivery and data quality
using the WHO/USAID Service Availability and Readi-
ness Assessment (SARA) tool, as a primary data source
for the analytical review. The SARA provides key infor-
mation on the state of the health system in terms of
service availability, as well as the readiness of the facil-
ities to provide an adequate level of service. Monitoring
facility-level performance provides information on
whether health services are present and are being
provided at the expected level, and gives an indication of
how investments in the formal health sector are result-
ing in changes at the level of service delivery. This
affects utilization of services and ultimately impacts
population-level outcome measures.
Providing an enabling working environment is a
requirement for an effective and functional health care
delivery system. Such enabling environment includes the
physical infrastructure and the availability of basic
requirements for delivering quality services. The assess-
ment included a review of health facility records in
family planning and contraception, to assess the
availability, type and range of commodities offered.
Analysis of readiness to provide family planning
services was assess based on the presence of the six
tracer items i.e. guidelines for family planning, staff
trained in family planning in the past 2 years, blood
pressure apparatus, combined oral contraceptive pills,
injectable contraceptives and male condoms.
Quantitative data from the mapping and facility assess-
ment survey will be entered into an electronic database
using SPSS and Epidata 3.1. The data will be from the
facility’s situation analysis i.e. interview with key staff
and facility records. Descriptive analysis will include
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computing the frequencies and proportions of categor-
ical variables while mean and other measures of central
tendency will be computed to describe continuous
variables.
Qualitative data will be analyzed using qualitative
analytical tools such as NVIVO. It will be based on in-
formation collected through focus groups with clients in
the ZIKV-affected sites in the catchment areas of health
facilities. Qualitative content analysis will be used to
analyze the focus group interview data. All interviews
will be transcribed verbatim and then analyzed following
the general approach of content analysis. The coding
process strategy will focus the data analysis on informa-
tion that unexpectedly emerges from empirical evidence.
Two researchers will analyze the data and will be guided
by general questions, specific questions, and compari-
sons. The coding method and progress will be systemat-
ically discussed between the researchers and the project
coordinator. The results will be translated into English.
Data will not include any identifying information of any
participant, and instead ID numbers will be used for
identification.
The HQ team based in Geneva, in conjunction with PI
and project team, will be responsible for the data
analysis. The analysis process will begin while data col-
lection is still on-going in order to assess progress and
determine any data collection problems and/or patterns.
Quality assurance
The investigator and project team will be trained on the
study purpose, design, quality assurance, reporting
mechanisms and data collection tools. Data collectors
will also be trained to use the study questionnaire/tool
for data collection from the facilities and entering the
survey data. Experts will conduct the focus group discus-
sion. Surveyors will be trained on data collection, trans-
mission, verification, storage and primary analysis to
assess errors.
All data will be double-entered into existing software
used by two separate data operators. Measures will be
taken to ensure the quality of collected data. All the
forms will be checked on a daily basis for completeness,
logical errors, and unclear or irrelevant responses. The
principal investigator (PI) and project team will make
monitoring visits to ensure the quality of data and
adherence to the study protocol. If needed, refresher
training will be arranged to enhance understanding of
data collection tools.
Scientific and ethical review
Scientific review and approval of the proposal has
already been obtained from Research Projects Review
Panel, the external review body of the Department of
Reproductive Health, and Research (WHO/RHR)
including the UNDP/UNFPA/WHO/World Bank Special
Programme of Research, Development, and Research
Training in Human Reproduction (HRP). Ethical
approval has also been obtained from WHO Research
Ethics Review Committee.
Project deliverables
Key outputs from this study will be as follow:
1. a map of all facilities providing contraception and
abortion/post-abortion care services in selected
ZIKV-affected areas of participating countries
2. facility assessment modules on contraception and
abortion/post-abortion care
3. assessment report with key findings and
recommendations for improving service availability
and quality of care in contraceptive and abortion
care services
4. Key findings from focus group discussions report
Timeline and tasks
We anticipate that this study will take approx. 18 months
to complete. Tools will be developed and facilities will
be mapped in affected areas during the first 2 months.
After this, the data collection will commence and will
take 3 months. This will involve data collector training
with the study tool, followed by assessment of facilities
and data collection in conjunction with focus group
interviews in communities. Data entry and analysis will
take 2 months. In the following 3 months, reports will
be written, and dissemination meetings will be held with
the Ministries of Health, health managers and stake-
holders to report key findings and areas for improve-
ment. After the groundwork is completed with the first
round of assessment, there will be a 6-month break in
the study before the second and third rounds of surveys
are completed. The second round will consist of
2 months of rapid assessment and data collection of
selected facilities and focus group interviews in commu-
nities. Data entry, analysis and comparisons will be done
in the following month to see what changes have hap-
pened since the first round, after which there will be
1 month for report writing and dissemination meetings
with the Ministries of Health, health managers and
stakeholders. The last round of data collection and ana-
lysis will be done with the same 4-month breakdown as
the second round.
Discussion
The data derived from this project will provide a better
understanding of the impact of ZIKV on contraception
and abortion/post abortion care programs at the regional
and community level to policy makers and health
managers to develop and strengthen policies and
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services to be more responsive to community needs.
These policies and services will relate to ensuring
availability of adequate method mix and to ensuring
accessible and affordable, women centred services in
contraception and safe abortion.
This study will provide a map of facilities in ZIKV-
affected areas in Brazil, Colombia and Honduras. It will
also assess the readiness of sampled facilities to provide
contraception, abortion (where possible) and post-
abortion care services. These important data will be
given to Ministries of Health with the aim of strengthen-
ing the health system to ensure good-quality care in
ZIKV-affected areas.
The study also has implications on future steps to-
wards addressing the ZIKV epidemic in Latin America.
The results of this study will aid in understanding
service gaps in health systems and formulating interven-
tions to improve facilities’ readiness to provide contra-
ception and abortion/post-abortion care services in the
face of the ZIKV epidemic and beyond.
The results and insights gleaned from this study will
guide future research and interventions that focus on
overcoming access and utilization barriers, and may
guide the development of a planning preparedness
model for other countries i.e. provide a set of tools and
processes, which can be applied in other settings, to en-
sure consistent quality reproductive healthcare in the
context of health emergencies.
Abbreviations
FGD: Focus group discussions; MVA: Manual and vacuum aspiration; PHEIC: Public
health emergency of international concern; PI: Principal investigator; SARA: Service
availability and readiness assessment; SPSS: Statistical package for the social
sciences; WHO: World Health Organization; ZIKV: Zika virus
Funding
The study is funded by Large Anonymous Donor under the Grant ID 5149
for Women, Communities, and Health Systems in the Context of Zika.
The funding sources did not play a role in the study design, in the writing of
the report, or in the decision to submit the article for publication.
Availability of data and materials
It is a study protocol so doesn’t have any specific data.
Authors’ contributions
All authors contributed equally and have read and approved the final version.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
All authors have agreed and have given consent for submission for publication.
Ethics approval and consent to participate
For facility assessment and focus group discussion ethical approval has been
obtained from WHO Research Ethics Review Committee under the project
ID: A65912003747.
Disclaimer
This report contains the collective views of an international group of experts,
and does not necessarily represent the decisions or the stated policy of the
World Health Organization.
Received: 13 December 2016 Accepted: 7 January 2017
References
1. Rasmussen SA, Jamieson DJ, Honein MA, Petersen LR. Zika virus and birth
defects–reviewing the evidence for causality. N Engl J Med. 2016;374:1981–7.
2. Cauchemez S, Besnard M, Bompard P, Dub T, Guillemette-Artur P, Eyrolle-
Guignot D, Salje H, Van Kerkhove MD, Abadie V, Garel C, et al. Association
between Zika virus and microcephaly in French Polynesia, 2013-15: a
retrospective study. Lancet. 2016;387:2125–32.
3. Costello A, Dua T, Duran P, Gülmezoglu M, Oladapo OT, Perea W, Pires J,
Ramon-Pardo P, Rollins N, Saxena S. Defining the syndrome associated with
congenital Zika virus infection. Bull World Health Organ. 2016;94:406–406A.
4. Brasil P, Pereira JP, Raja Gabaglia C, Damasceno L, Wakimoto M, Ribeiro
Nogueira RM, Carvalho de Sequeira P, Machado Siqueira A, Abreu de
Carvalho LM, Cotrim da Cunha D, et al. Zika Virus Infection in Pregnant
Women in Rio de Janeiro. N Engl J Med. 2016;375(24):2321–34.
5. World Health Organization. WHO statement on the first meeting of the IHR
Emergency Committee on Zika virus and observed increase in neurological
disorders and neonatal malformations. Geneva: World Health Organization.
http://www.who.int/mediacentre/news/statements/2016/1st-emergency-
committee-zika/en/. Accessed 12 Jan 2017.
6. World Health Organization. Prevention of sexual transmission of Zika virus:
interim guidance update. Geneva: World Health Organization; 2016. http://
www.who.int/csr/resources/publications/zika/sexual-transmission-
prevention/en/. Accessed 12 Jan 2017.
7. Aiken AR, Scott JG, Gomperts R, Trussell J, Worrell M, Aiken CE. Requests for
Abortion in Latin America Related to Concern about Zika Virus Exposure. N
Engl J Med. 2016.
8. Ugaz JI, Chatterji M, Gribble JN, Mitchell S. Regional trends in the use of
short-acting and long-acting contraception accessed through the private
and public sectors. Int J Gynaecol Obstet. 2015;130 Suppl 3:E3–7.
9. Ali MM, Cleland J. Sexual and reproductive behaviour among single women
aged 15-24 in eight Latin American countries: a comparative analysis. Soc
Sci Med. 2005;60:1175–85.
10. Diniz SG, d’Oliveira AF, Lansky S. Equity and women’s health services for
contraception, abortion and childbirth in Brazil. Reprod Health Matters.
2012;20:94–101.
11. Guttmacher Institute. Sexual and Reproductive Health Research Analysis:
Latin America & the Caribbean. 2016. https://www.guttmacher.org/
geography/latin-america-caribbean. Accessed 12 Jan 2017.
12. Singh S, Darroch JE, Ashford LS. Adding it up: the costs and benefits of investing
in sexual and reproductive health. New York: Guttmacher Institute; 2014.
13. Sedgh G, Singh S, Hussain R. Intended and unintended pregnancies
worldwide in 2012 and recent trends. Stud Fam Plann. 2014;45:301–14.
14. Sedgh G, Bearak J, Singh S, Bankole A, Popinchalk A, Ganatra B, Rossier C,
Gerdts C, Tunçalp Ö, Johnson BR, et al. Abortion incidence between 1990
and 2014: global, regional, and subregional levels and trends. Lancet. 2016;
388:258–67.
15. United Nations. Population division: world abortion policies. New York: UN;
2011.
16. Menéndez C, Lucas A, Munguambe K, Langer A. Ebola crisis: the unequal
impact on women and children’s health. Lancet Glob Health. 2015;3:e130.
17. Garcia-Subirats I, Vargas I, Mogollón-Pérez AS, De Paepe P, da Silva MR,
Unger JP, Borrell C, Vázquez ML. Inequities in access to health care in
different health systems: a study in municipalities of central Colombia and
north-eastern Brazil. Int J Equity Health. 2014;13:10.
18. Mutter J. Disasters widen the rich-poor gap. Nature. 2010;466:1042.
19. Barden-O’Fallon J, Barry MA, Brodish P, Hazerjian J. Rapid Assessment of
Ebola-Related Implications for Reproductive, Maternal, Newborn and Child
Health Service Delivery and Utilization in Guinea. PLOS Currents Outbreaks.
2015. doi:10.1371/currents.outbreaks.0b0ba06009dd091bc39ddb3c6d7b0826.
20. Delamou A, Hammonds RM, Caluwaerts S, Utz B, Delvaux T. Ebola in
Africa: beyond epidemics, reproductive health in crisis. Lancet.
2014;384:2105.
21. Roa M. Zika virus outbreak: reproductive health and rights in Latin America.
Lancet. 2016;387:843.
22. World Health Organization. Service availability and readiness assessment
(SARA): implementation guide. Geneva: World Health Organization; 2015.
http://www.who.int/healthinfo/systems/sara_implementation_guide/en/.
Accessed 12 Jan 2017.
Ali et al. Reproductive Health  (2017) 14:18 Page 6 of 7
23. World Health Organization. Safe abortion: technical and policy guidance for
health systems. 2nd ed. Geneva: World Health Organization; 2012. http://
www.who.int/reproductivehealth/publications/unsafe_abortion/
9789241548434/en/. Accessed 12 Jan 2017.
24. Columbine M, Busza J, Cleland J, Campbell O. Social science methods for
research on sexual and reproductive health. Geneva: World Health
Organization; 2012.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Ali et al. Reproductive Health  (2017) 14:18 Page 7 of 7
